NCT06670300 2024-11-01Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal CancerHenan Cancer HospitalPhase 2 Not yet recruiting20 enrolled